Rapid assessment tool for Haemophilus influenzae type b disease in developing countries

Area of Science:

• Pediatric infectious diseases
• Vaccinology
• Epidemiology

Background:

• Haemophilus influenzae type b (Hib) continues to cause significant child mortality globally, particularly in developing countries.
• Despite effective conjugate vaccines, limited awareness of Hib disease burden hinders control efforts.
• Developing countries face challenges in accurately tracking Hib disease incidence.

Purpose of the Study:

• To introduce and evaluate a rapid assessment tool for estimating national Hib meningitis and pneumonia rates.
• To provide timely data for countries to understand the impact of Hib disease.
• To support informed decision-making regarding Hib vaccination strategies.

Main Methods:

• Development of a tool to assess retrospective local data on Hib meningitis and pneumonia over 7–10 days.
• Application of the tool to data from 11 countries across Africa, the Middle East, and Asia.
• Analysis of estimated incidence rates based on available data quality.

Main Results:

• Hib meningitis rates varied widely, from over 50 per 100,000 children in Ghana and Uganda to under 15 per 100,000 in Iran, Jordan, and Uzbekistan.
• The accuracy of the estimated rates was influenced by the quality of the collected local data.
• The tool demonstrated feasibility for rapid assessment in diverse settings.

Conclusions:

• The developed Hib rapid assessment tool offers a practical method for countries to quickly estimate Hib disease burden.
• Timely data on Hib disease incidence is crucial for advocating for and implementing effective control measures, including vaccination.
• Further refinement and validation of the tool may enhance its utility in global child health initiatives.